STAR-121: A Phase III Randomized Study of Domvanalimab and Zimberelimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated Metastatic Non–Small Cell Lung Cancer With No Actionable Gene Alterations
Titel:
STAR-121: A Phase III Randomized Study of Domvanalimab and Zimberelimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated Metastatic Non–Small Cell Lung Cancer With No Actionable Gene Alterations
Auteur:
Rodriguez-Abreu, Delvys Bosch-Barrera, Joaquim Gray, Jhanelle E. Ahn, Myung-Ju Johnson, Melissa Yu, Xinwei Mohammad, Saad Chen, Xueying Todd, Trever Kim, Jongseok Reck, Martin